This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Goals and Learning Outcomes

Multiple myeloma is hematological cancer that involves a plasma cell, a type of white blood cell. Abnormal plasma cells, called myeloma cells, grow uncontrolled in a manner that produces bulky tumors in the body’s bone marrow. Patients with multiple myeloma often experience symptoms such as fatigue, diarrhea, peripheral neuropathies, and pain that decrease quality of life while presenting a management challenge for the healthcare team. New technologies and advances in medication have offered treatment options for patients that develop resistance to conventional therapy.


The goal of this course is to provide nurses with the latest knowledge about the diagnosis of multiple myeloma, as well as treatment options and clinical interventions for the disease.

After taking this course, you should be able to:

  • List the symptoms and methods used to diagnose multiple myeloma
  • Describe current treatment options for multiple myeloma
  • Define the supportive care issues related to treatment for multiple myeloma
  • Identify signs and symptoms, diagnostic workup, and treatment options for multiple myeloma.
  • Recognize the supportive care needs related to treatment for multiple myeloma.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 06/01/22

Course Authors

4.4 Average

Course Reviews

4363 reviews

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.